Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Animal or plant cell
Reexamination Certificate
2001-01-24
2002-11-26
Wortman, Donna C. (Department: 1648)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Animal or plant cell
C424S093210, C435S001100, C435S371000, C435S402000, C435S408000, C623S015120
Reexamination Certificate
active
06485724
ABSTRACT:
BACKGROUND OF THE INVENTION
Human Keratinocytes
Human keratinocytes isolated from stratified squamous epithelia can be readily cultivated in vitro (reviewed in Leigh, et al., 1994). Cultivated keratinocytes replicate readily during early passage and can generate large numbers of cells which exhibit certain features of squamous differentiation in vivo. When cultured normal human keratinocytes are transplanted onto mice, epidermal tissue architecture is regenerated over time in an orderly fashion (Breitkreutz, et al., 1997). The ease of cultivation and transplantation of human keratinocytes coupled with the accessibility of skin for the grafting procedure and subsequent monitoring, make this somatic cell type attractive for therapeutic gene delivery. However, due to the initiation of terminal differentiation, transgene expression in keratinocytes is consistently lost regardless of the gene expression strategy used. Several reports have shown that genetically engineered human keratinocytes can recapitulate full thickness epidermis, thus demonstrating that cells with stem cell-like properties were present in the transplanted population of cells (Choate and Khavari, 1997; Choate, et al., 1996; Gerrard, et al., 1993; Garlick, et al., 1991; Greenhalgh, et al., 1994; Vogel, 1993, Fenjves, 1994).
In Vitro Tissue Culture Assays Utilizing Human Cells Derived from Stratified Sauamous Epithelia
In vitro assays using monolayer cultures of adherent cells which maintain the normal in vivo tissue context do not exist for human tissues. Animal models do have the capacity to mimic some of the processes involved in the response of human tissue therapies. However, animal systems lend themselves only to qualitative and subjective scoring of tumor repopulation. Historically, simple in vitro growth assays have used monolayer cultures of rodent or human cell lines on plastic tissue culture dishes. Colony size or cell number are assessed in order to estimate the extent of survival and repopulation of cancer cells following radiation treatment. A major drawback of this approach is that it does not account for any adhesive or paracrine growth factor signals within the tumor cell environment. For this reason, studies on the growth of tumor cells in the absence of normal surrounding tissue may not accurately reflect the in vivo growth characteristics of tumor cells.
For example, human head and neck (H&N) tumors are diagnosed in 43,000 patients in the United States every year and in over 750,000 patients worldwide. Although tumor recurrence near the site of the primary tumor is the predominant cause of treatment failure and death for these patients, little is know about the molecular events contributing to tumor regrowth following treatment. Clinical and radiobiological evidence suggests that tumor proliferation rates may actually increase following wounding due to radiation exposure (Hall, E. J., 1988; Petereit, D. G., et al., 1995). It has been suggested that the wound environment provides potent tumor growth signals (Haddow, A., 1972). For example, extracellular matrix (ECM) glycoproteins present in the wound bed provide and/or sequester potent growth stimuli required for normal tissue regeneration. It is clear from these observations that the tissue context in which a tumor initially develops and/or regrows following failed cancer treatment may have significant impact on tumor growth.
Needed in the art of cell biology is a spontaneously immortalized human keratinocyte cell line with near normal chromosomal complement and a method for using this immortalized cell line in an in vitro tissue assay.
SUMMARY OF THE INVENTION
In one embodiment, the present invention is an immortalized human keratinocyte cell line, wherein the cell line comprises a normal chromosomal complement of 46 with the exception of an extra isochromosome on the long arm of chromosome 8. In one particularly advantageous embodiment, the cell line is ATCC CRL 12191.
In another embodiment, the present invention is a transgenic immortalized human keratinocyte cell line transfected with a heterologous gene. This gene may be a marker gene, most preferably green fluorescent protein (GFP).
The present invention is also a method of assaying the effect of a test tumor cell therapeutic agent by obtaining a human stratified squamous epithelial cell culture comprising malignant squamous epithelial cells, preferably human squamous carcinoma cells (SCC), and spontaneously immortalized human keratinocytes. This culture is then formed into a reconstructed epidermis. One may then treat the epidermis with a test tumor cell therapeutic agent and evaluate the growth of the SCC within the epidermis.
It is an advantage of the present invention that an immortalized keratinocyte cell line is provided.
Other objects, features and advantages of the present invention will become apparent after review of the specification, claims and drawings.
REFERENCES:
patent: 5491084 (1996-02-01), Calfie et al.
L. Allen-Hoffmann, et al.,Proc. Nat'l. Acad. Sci. USA81: 7802-7806, 1984.
B.L. Allen-Hoffmann, et al., “Use of RHEK-1 Immortalized Human Keratinocytes for Detection of Induced Mutation at the Hypoxanthine-guanine Phosphoriboxyltransferase Locus,” Inter. J. Oncol. 3: 619-625, 1993.
H.P. Baden, et al., “Isolation and Characterization of a Spontaneously Arising Long-lived Line of Human Keratinocytes (NM1),”In Vitro Cell. Dev. Biol.23 (3): 205-213, 1987.
P. Boukamp, et al., “Cell Keratinization in a Sponstaneously Immortalized Diploid Human Keratinocyte Cell Line,”J. Cell Biol.106: 761-771, 1988.
P. Boukamp, et al., “Norman Keratinization in a Spontaneously Immortalized Aneuploid Humnan Keratinocyte Cell Line,” J. Cell Biol. 106: 761-771, 1988.
J.A. Garlick and L.B. Taichman, “Fate of Human Keratinocytes during Reepithelialization in an Organotypic Culture Model,” Lab Invest. 70 (6): 916-924, 1994.
J.A. Garlick, et al., “Re-epithelialization of Human oral Keratinocytesin vitro,”J. Dent. Res. 75(3): 912-918, 1996.
J.A. Garlick, “Skin Substitutes—Tissue Models for Cancer Biology,”Bioengineering of Skin Substitutes,Boston, MA, Sep. 18-19, 1997.
C. Gilles, et al., “Immortalization of Human Cervical Keratinocytes by Human Paillomavirus Type 33,”Int. J. Cancer53: 872-879, 1993.
M.A. Pickart, et al., “Development of an Organotypic Culture System for the Study of Human Squamous Cell Carcinoma,”Proc. Am. Assoc. Canc. Res.40:192, 1999 (abstract).
R.H. Rice, et al., “Elevation of Cell Cycle Control Proteins During Spontaneous Immortalization of Human Keratinocytes,” Moll. Biol. Cell 4: 185-194, 1993.
D. Strickland, “Organogenesis gets Approval from FDA for Graftpatch; Stock Jumps 7 Percent,” Bioworld Today 8 (154): 1-4, 1997.
Allen-Hoffmann B. Lynn
Schlosser Sandra J.
Quarles & Brady LLP
Wisconsin Alumni Research Foundation
Wortman Donna C.
LandOfFree
Immortalized human keratinocyte cell line does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immortalized human keratinocyte cell line, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immortalized human keratinocyte cell line will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2925460